However, CpG island methylation of the WT1/WT1-AS promoter is higher in ovarian clear cell adenocarcinoma, compared with ovarian serous adenocarcinoma, resulting in the differential expression of WT1-AS between these two tumor types. The gene discussed is WT1; the disease is ovarian clear cell adenocarcinoma.